Professor of Radiation Oncology, University KY College of Medicine
Radiation Oncology
Dr. Ronald C. McGarry, MD
|
|
Give Review
Doctor Ronald C. McGarry, MD works in the field of Radiation Oncology. He has 3 awards "America's Top Doctors", "America's Top Doctors for Cancer" and "Whos Who in Medicine and Healthcare". Ronald McGarry is a published MD. He has 47 publications published. The most current publication "Development of three-dimensional lung multicellular spheroids in air- and liquid-interface culture for the evaluation of anticancer therapeutics." He accepts Medicare.
Publications
- Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor Microenvironment.
- Development of three-dimensional lung multicellular spheroids in air- and liquid-interface culture for the evaluation of anticancer therapeutics.
- Integrating stereotactic body radiation therapy in stage II/III non-small cell lung cancer: is local control important?
- High-Performing Dry Powder Inhalers of Paclitaxel DPPC/DPPG Lung Surfactant-Mimic Multifunctional Particles in Lung Cancer: Physicochemical Characterization, In Vitro ...
- Total target volume is a better predictor of whole brain dose from gamma stereotactic radiosurgery than the number, shape, or location of the lesions.
- Characterization and Aerosol Dispersion Performance of Advanced Spray-Dried Chemotherapeutic PEGylated Phospholipid Particles for Dry Powder Inhalation Delivery in Lun...
- Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphos...
- Stereotactic Body Radiation Therapy Can Be Used Safely to Boost Residual Disease in Locally Advanced Non-Small Cell Lung Cancer: A Prospective Study.
- TH-C-BRA-08: Prescription Isodose Line Definitions and Not Set Up Uncertainty Limit the Normal Tissue Irradiation in SBRT of Lung Patients.
- SU-E-T-400: SBRT Dose Verification Using Monte Carlo Simulation.
- Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation do...
- A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypof...
- Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.
- Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119).
- Iododeoxyuridine uptake in proliferating smooth muscle cells in vitro.
- Stereotactic body radiotherapy for bilateral primary lung cancers: the Indiana University experience.
- Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases.
- Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study.
- Effect of varying CT section width on volumetric measurement of lung tumors and application of compensatory equations.
- Dendritic cells transfected with interleukin-12 and pulsed with tumor extract inhibit growth of murine prostatic carcinoma in vivo.
- Observation-only management of early stage, medically inoperable lung cancer: poor outcome.
- Induced morphological changes in human small cell lung carcinoma cells.
- Human melanoma-associated antigen expression on human neuroblastoma cells: effects of differentiation inducers.
- Optimal photon energies for IUdR K-edge radiosensitization with filtered x-ray and radioisotope sources.
- Effects of retinoic acid and bromodeoxyuridine on human melanoma-associated antigen expression in small cell lung carcinoma cells.
- Superior vena cava obstruction due to prostate carcinoma.
- Please pass the strychnine: the art of Victorian pharmacy.
- Chemotherapy response rates in recurrent/progressive pediatric glioma; results of a systematic review.
- Treatment resistant small cell carcinoma of the cervix.
- Intravesical chemotherapy prophylaxis in primary superficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials.
- Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials.
- Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
- Pulmonary hilar stereotactic body radiation therapy in the rat.
- Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lu...
- Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treat...
- Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.
- Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.
- A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer.
- Turf war: medical men take on the establishment in Niagara Falls, Ontario.
- FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer.
- Stereotactic body radiation therapy for early-stage non-small-cell lung cancer.
- Stereotactic body radiation therapy for nonpulmonary primary tumors.
- Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites.
- Stereotactic body radiation therapy for oligometastases.
- Stereotactic body radiation therapy: a novel treatment modality.
- Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy.
Schools
University of Calgary Faculty of Medicine
McMaster University
University Western OntLondon Regl Canc Center
Queen39s University
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Whos Who in Medicine and Healthcare
Education
-
University of Calgary Faculty of Medicine
Hospital
-
University of Kentucky Albert B. Chandler Hospital
Drug Facts
| NPI NUMBER | 1144284894 | |
| NPPES Provider LastName | MCGARRY | |
| NPPES Provider FirstName | RONALD | |
| NPPES Provider ZIPCode | 405360294 | |
| NPPES Provider State | KY | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 12.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144284894 |
| Last Name Of The Provider | MCGARRY |
| First Name Of The Provider | RONALD |
| View All |
Similar Doctors
|
|
Mahesh R. Kudrimoti, MB
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jacqueline R. Matar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Falguni Amin-Zimmerman, MD |
|
|
Dr. Alan C. Beckman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcus E. Randall, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Pushpa M. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janalyn Prows, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justine M. Yoneda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam J. Smith, MD |
|
|
Dr. Sameera S. Kumar, MD |
|
|
Dr. Marguerite A. Sellitti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Padma I. Raju, MD |
|
|
Dr. Marta S. Hayne, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory C. Treharne, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bryan M. Rabatic, MD |
|
|
Dr. Charles E. Wooten, MD
This Doctor is OpenDoctor Recommended.
|